AIMS: We investigated the expression of claudins 18 and 10 in a large set of primary lung carcinomas. METHODS AND RESULTS: Immunohistochemical expression of claudin 18 was seen in 12.7 % and claudin 10 in 12.5 % of lung carcinomas. Their expression significantly associated with each other (p<0.001). The expression of claudin 18 and 10 was most prominent in lung adenocarcinomas which displayed positivity in 21.2% and 23.4 % of cases. Female patients had more often claudin 18 and 10 positive tumors, also separately in adenocarcinomas. Interestingly, claudin 10 (p=0.036) and claudin 18 (p=0.001) were more common in tumours of nonsmokers. In adenocarcinomas claudin 18 predicted a better survival (p=0.032). In Cox multivariate analysis, claudin 18 had an independent prognostic value (p=0.027). CONCLUSION: The results show that both claudins are most commonly expressed in lung adenocarcinomas and they are more occasionally detected in other histological tumour types. Curiously, female patients and non-smokers express these claudins more commonly suggesting that they may play a part in the carcinogenesis of tobacco unrelated carcinoma. Claudin 18 associated with a better survival in lung adenocarcinoma and had an independent prognostic value and may thus be used in the evaluation of patient prognosis.
AIMS: We investigated the expression of claudins 18 and 10 in a large set of primary lung carcinomas. METHODS AND RESULTS: Immunohistochemical expression of claudin 18 was seen in 12.7 % and claudin 10 in 12.5 % of lung carcinomas. Their expression significantly associated with each other (p<0.001). The expression of claudin 18 and 10 was most prominent in lung adenocarcinomas which displayed positivity in 21.2% and 23.4 % of cases. Female patients had more often claudin 18 and 10 positive tumors, also separately in adenocarcinomas. Interestingly, claudin 10 (p=0.036) and claudin 18 (p=0.001) were more common in tumours of nonsmokers. In adenocarcinomasclaudin 18 predicted a better survival (p=0.032). In Cox multivariate analysis, claudin 18 had an independent prognostic value (p=0.027). CONCLUSION: The results show that both claudins are most commonly expressed in lung adenocarcinomas and they are more occasionally detected in other histological tumour types. Curiously, female patients and non-smokers express these claudins more commonly suggesting that they may play a part in the carcinogenesis of tobacco unrelated carcinoma. Claudin 18 associated with a better survival in lung adenocarcinoma and had an independent prognostic value and may thus be used in the evaluation of patient prognosis.
Authors: Zhijian Gao; Xiaoyin Xu; Bruce McClane; Qing Zeng; Babak Litkouhi; William R Welch; Ross S Berkowitz; Samuel C Mok; Elizabeth I O Garner Journal: Clin Cancer Res Date: 2010-12-01 Impact factor: 12.531
Authors: Patricia Pintor Dos Reis; Rikki R Bharadwaj; Jerry Machado; Christina Macmillan; Melania Pintilie; Mahadeo A Sukhai; Bayardo Perez-Ordonez; Patrick Gullane; Jonathan Irish; Suzanne Kamel-Reid Journal: Cancer Date: 2008-12-01 Impact factor: 6.860
Authors: Zarir E Karanjawala; Peter B Illei; Raheela Ashfaq; Jeffrey R Infante; Kathleen Murphy; Akhilesh Pandey; Richard Schulick; Jordan Winter; Rajni Sharma; Anirban Maitra; Michael Goggins; Ralph H Hruban Journal: Am J Surg Pathol Date: 2008-02 Impact factor: 6.394
Authors: Biljana Jovov; Christina M Van Itallie; Nicholas J Shaheen; Johnny L Carson; Todd M Gambling; James M Anderson; Roy C Orlando Journal: Am J Physiol Gastrointest Liver Physiol Date: 2007-10-11 Impact factor: 4.052
Authors: Beiyun Zhou; Per Flodby; Jiao Luo; Dan R Castillo; Yixin Liu; Fa-Xing Yu; Alicia McConnell; Bino Varghese; Guanglei Li; Nyam-Osor Chimge; Mitsuhiro Sunohara; Michael N Koss; Wafaa Elatre; Peter Conti; Janice M Liebler; Chenchen Yang; Crystal N Marconett; Ite A Laird-Offringa; Parviz Minoo; Kunliang Guan; Barry R Stripp; Edward D Crandall; Zea Borok Journal: J Clin Invest Date: 2018-02-05 Impact factor: 14.808
Authors: Paula Giménez-Mascarell; Carlotta Else Schirrmacher; Luis Alfonso Martínez-Cruz; Dominik Müller Journal: Front Pediatr Date: 2018-04-09 Impact factor: 3.418